MediThinQ and Synovis Alliance Transform Microsurgery with SHIYA Platform Distribution Agreement

MediThinQ and Synovis Micro Companies Alliance: A New Era in Microsurgery

On June 18, 2026, a groundbreaking partnership was announced between MediThinQ, a leading South Korean innovator in surgical visualization technologies, and Synovis Micro Companies Alliance, Inc., a subsidiary of Baxter International, Inc. This strategic agreement is set to redefine the landscape of microsurgery through the global distribution of MediThinQ's SHIYA 3D Visualization Platform.

The Essence of the Agreement

This exclusive multi-year distribution deal empowers Synovis MCA to utilize its deep expertise in microsurgery, leveraging longstanding relationships with hospitals and eminent surgeons to enhance the accessibility of SHIYA worldwide. Details regarding the terms of the agreement have not been made public, but the implications for the medical community are significant.

SHIYA offers a revolutionary alternative to traditional optical microscopes, which often limit visibility and hamper surgical processes, providing an advanced digital surgical experience. With this partnership, MediThinQ aims to enhance surgical precision and streamline workflows in operating rooms across various healthcare systems.

Transition from Optical to Digital

For years, surgeons have utilized optical microscopes, which can affect individual posture and visibility among the surgical team. MediThinQ’s SHIYA eliminates these constraints by introducing a digital platform enhanced with a high-resolution digital exoscope and a proprietary wearable display known as SCOPEYE.

This innovative apparatus allows for magnification up to 20 times and fosters better coordination during surgeries by enabling the team to share the same visual feed. This switch from optical to digital visualization paves the way for data-driven surgeries that utilize advanced analytics, artificial intelligence, and robotics.

Additionally, the portability and adaptability of SHIYA address challenges present in conventional setups, often costly and heavy in resource-dependent settings. By making digital visualization more accessible, MediThinQ’s agreement with Synovis aims to democratize advanced surgical techniques previously limited to well-resourced institutions.

Clinical Validation and Recognition

SHIYA has already been deployed in over 100 surgical procedures globally, with findings gaining the support of peer-reviewed studies. In a notable review article published in 2025, Prof. Joon-pio Hong, MediThinQ's Chief Medical Officer, elaborated on the potential of digital exoscopy in microsurgery, highlighting features such as augmented reality and real-time data application.

Moreover, the ergonomic benefits of SHIYA have been documented by researchers, indicating a significant shift towards integrating digital platforms into microsurgical practices. Dr. Peter Neligan, a prominent figure in reconstructive microsurgery, hailed SHIYA as the future of reconstructive surgery by acknowledging its potential for improving surgical outcomes.

The Road Ahead

As MediThinQ and Synovis embark on this transformative journey, they envision a phased approach for the rollout of SHIYA. This strategy entails a careful evaluation of regulatory requirements and market conditions in individual countries to ensure both compliance and readiness.

Seung Joon IM, the founder and CEO of MediThinQ, emphasizes that this collaboration aligns with the company's mission to remove the limitations posed by traditional optical systems, enhancing accessibility and fostering surgical innovation.

Michael Campbell, President of Synovis MCA, echoed this sentiment, emphasizing their commitment to developing the most trusted solutions for microsurgeons worldwide. By cooperating on SHIYA’s launch, they aim to establish a strong foundation that fosters growth and cultivates innovative solutions in surgical practices.

Additional Opportunities

Looking beyond just 3D visualization, MediThinQ envisions a broader concept of “3D Surgical Intelligence,” integrating visualization, data capture, and analytics into a cohesive surgical environment. This paradigm aims not only to enhance surgical techniques but also to evolve how surgical data is perceived and utilized, reflecting the future of healthcare practices.

In conclusion, the strategic partnership between MediThinQ and Synovis MCA marks a pivotal moment in the field of microsurgery. As SHIYA takes center stage in operating rooms around the globe, it foreshadows a new era defined by efficiency, cooperation, and technological advancement in surgical practices.